BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 29893346)

  • 21. Mitoxantrone and etoposide with or without intermediate dose cytarabine for the treatment of primary induction failure or relapsed acute myeloid leukemia.
    Trifilio SM; Rademaker AW; Newman D; Coyle K; Carlson-Leuer K; Mehta J; Altman J; Frankfurt O; Tallman MS
    Leuk Res; 2012 Apr; 36(4):394-6. PubMed ID: 22172465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mito-flag as salvage therapy for relapsed and refractory acute myeloid leukemia.
    Hänel M; Friedrichsen K; Hänel A; Herbst R; Morgner A; Neser S; Nicklisch M; Teich M; Ehninger G; Fiedler F
    Onkologie; 2001 Aug; 24(4):356-60. PubMed ID: 11574763
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term disease-free survival after gemtuzumab, intermediate-dose cytarabine, and mitoxantrone in patients with CD33(+) primary resistant or relapsed acute myeloid leukemia.
    Chevallier P; Delaunay J; Turlure P; Pigneux A; Hunault M; Garand R; Guillaume T; Avet-Loiseau H; Dmytruk N; Girault S; Milpied N; Ifrah N; Mohty M; Harousseau JL
    J Clin Oncol; 2008 Nov; 26(32):5192-7. PubMed ID: 18854573
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bilateral ovarian granulocytic sarcoma as the primary manifestation of acute myelogenous leukemia treated with allogenic stem cell transplantation: A case report.
    Choi JY; Kim HY; Kang MG; Shin JK; Lee WS; Song HN
    Medicine (Baltimore); 2019 Dec; 98(52):e18390. PubMed ID: 31876710
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced-intensity conditioning with fludarabine and busulfan versus fludarabine and melphalan for patients with acute myeloid leukemia: a report from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    Baron F; Labopin M; Peniket A; Jindra P; Afanasyev B; Sanz MA; Deconinck E; Nagler A; Mohty M
    Cancer; 2015 Apr; 121(7):1048-55. PubMed ID: 25424330
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fractionated doses of gemtuzumab ozogamicin combined with 3 + 7 induction chemotherapy as salvage treatment for young patients with acute myeloid leukemia in first relapse.
    Malfuson JV; Konopacki J; Thepenier C; Eddou H; Foissaud V; de Revel T
    Ann Hematol; 2012 Dec; 91(12):1871-7. PubMed ID: 22820971
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Myeloid sarcoma of the breast in an aleukemic patient: a rare entity in an uncommon location.
    Nalwa A; Nath D; Suri V; Jamaluddin MA; Srivastava A
    Malays J Pathol; 2015 Apr; 37(1):63-6. PubMed ID: 25890617
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Salvage therapy with high-dose cytarabine and mitoxantrone in combination with all-trans retinoic acid and gemtuzumab ozogamicin in acute myeloid leukemia refractory to first induction therapy.
    Hütter-Krönke ML; Benner A; Döhner K; Krauter J; Weber D; Moessner M; Köhne CH; Horst HA; Schmidt-Wolf IG; Rummel M; Götze K; Koller E; Petzer AL; Salwender H; Fiedler W; Kirchen H; Haase D; Kremers S; Theobald M; Matzdorff AC; Ganser A; Döhner H; Schlenk RF
    Haematologica; 2016 Jul; 101(7):839-45. PubMed ID: 27036160
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical outcome of myeloid sarcoma in adult patients and effect of allogeneic stem cell transplantation. Results from a multicenter survey.
    Lazzarotto D; Candoni A; Filì C; Forghieri F; Pagano L; Busca A; Spinosa G; Zannier ME; Simeone E; Isola M; Borlenghi E; Melillo L; Mosna F; Lessi F; Fanin R
    Leuk Res; 2017 Feb; 53():74-81. PubMed ID: 28056398
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-Term Remission following Autologous Hematopoietic Cell Transplantation in a Patient with Multiple Nonleukemic Myeloid Sarcoma and a Review of the Literature.
    Liang Y; Gao J; Wu D; Li S; Chen H; Ding L; Tong J; Xu Y
    Acta Haematol; 2017; 137(3):117-122. PubMed ID: 28301836
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Lateral Neck Myeloid Sarcoma Presenting as Acute Otitis Externa.
    Mozafari R; Alimoghaddam K; Sotoude H; Asadollahi-Amin A
    Arch Iran Med; 2018 Nov; 21(11):544-546. PubMed ID: 30551696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clonal evolution including partial loss of human leukocyte antigen genes favoring extramedullary acute myeloid leukemia relapse after matched related allogeneic hematopoietic stem cell transplantation.
    Stölzel F; Hackmann K; Kuithan F; Mohr B; Füssel M; Oelschlägel U; Thiede C; Röllig C; Platzbecker U; Schetelig J; Illmer T; Schaich M; Seliger B; Hartmann A; Baretton G; Zietz C; Ehninger G; Schrock E; Bornhäuser M
    Transplantation; 2012 Apr; 93(7):744-9. PubMed ID: 22314337
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Donor cell leukemia developing after hematopoietic stem cell transplantation for multiple myeloma.
    Havelange V; Antoine-Poirel H; Saussoy P; Van Den Neste E; Ferrant A
    Acta Clin Belg; 2006; 61(2):82-6. PubMed ID: 16792340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isolated extramedullary relapse of acute myelogenous leukemia as a uterine granulocytic sarcoma in an allogeneic hematopoietic stem cell transplantation recipient.
    Maeng H; Cheong JW; Lee ST; Yang WI; Hahn JS; Ko YW; Min YH
    Yonsei Med J; 2004 Apr; 45(2):330-3. PubMed ID: 15119007
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sequential flavopiridol, cytosine arabinoside, and mitoxantrone: a phase II trial in adults with poor-risk acute myelogenous leukemia.
    Karp JE; Smith BD; Levis MJ; Gore SD; Greer J; Hattenburg C; Briel J; Jones RJ; Wright JJ; Colevas AD
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4467-73. PubMed ID: 17671131
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fludarabine and cytarabine combined chemotherapy followed by transfusion of donor blood stem cells for treating relapse of acute leukaemia after allogeneic haematopoietic stem cell transplantation.
    You Y; Li QB; Chen ZC; Li WM; Xia LH; Zhou H; Zou P
    Chin Med J (Engl); 2008 Sep; 121(18):1770-4. PubMed ID: 19080355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disseminated De Novo Myeloid Sarcoma in a 17-year-old Boy.
    Sandre MK; Liu A; Levy R
    Pediatr Dermatol; 2019 Jul; 36(4):509-510. PubMed ID: 30941787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Liposomal daunorubicine combined with cytarabine in the treatment of relapsed/refractory acute myeloid leukemia in children].
    Reinhardt D; Hempel G; Fleischhack G; Schulz A; Boos J; Creutzig U
    Klin Padiatr; 2002; 214(4):188-94. PubMed ID: 12165900
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liposomal daunorubicin, fludarabine, and cytarabine (FLAD) as bridge therapy to stem cell transplant in relapsed and refractory acute leukemia.
    De Astis E; Clavio M; Raiola AM; Ghiso A; Guolo F; Minetto P; Galaverna F; Miglino M; Di Grazia C; Ballerini F; Marani C; Pastori G; Mitscheunig L; Cruciani F; Lovera D; Varaldo R; Ghiggi C; Lemoli RM; Bacigalupo A; Gobbi M
    Ann Hematol; 2014 Dec; 93(12):2011-8. PubMed ID: 24989345
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myeloid Sarcoma of the Paranasal Sinuses in a Patient with Acute Myeloid Leukemia.
    Suzuki J; Harazaki Y; Morita S; Kaga Y; Nomura K; Sugawara M; Katori Y
    Tohoku J Exp Med; 2018 Oct; 246(2):141-146. PubMed ID: 30369515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.